Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts U.S. Investors Lead Oversubscribed $17m Placement December 8, 2025 Locksley Resources LimitedU.S. Investors Lead Oversubscribed $17m Placement December 8, 2025 Top 5 Canadian Mining Stocks This Week: Bayhorse Silver Runs With 73 Percent Gain December 6, 2025